With a vision of making breast screening accessible and affordable to all women, Alixir is the breast cancer detection system of the future.
It uses deep learning to segment and classify potential cancerous lesions on mammograms, leading to earlier detection and better patient outcomes. Alixir’s cloud infrastructure can easily integrate with PACS / BIS systems and enable scalable reporting on demand.
With an accuracy rate of over 95%, exceeding that of a radiologist, this digital mammogram is set to provide custom and instant reporting that is more accurate and cost-effective than ever before.
Find out more about Alixir at https://alixir.ai.